hVMAT2: A Target of Individualized Medication for Parkinson's Disease.
Xiong N, Li N, Martin E, Yu J, Li J, Liu J, Lee DY, Isacson O, Vance J, Qing H, Wang T, Lin Z.
Xiong N, et al. Among authors: lee dy.
Neurotherapeutics. 2016 Jul;13(3):623-34. doi: 10.1007/s13311-016-0435-5.
Neurotherapeutics. 2016.
PMID: 27137201
Free PMC article.